SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14C - Other definitive information statements:
SEC Accession No. 0001829126-23-008126
Filing Date
2023-12-20
Accepted
2023-12-20 06:30:38
Documents
1
Period of Report
2023-12-20

Document Format Files

Seq Description Document Type Size
1 DEF 14C organicellregen_def14c.htm DEF 14C 129330
  Complete submission text file 0001829126-23-008126.txt   130649
Mailing Address 3321 COLLEGE AVENUE SUITE 246 DAVIE FL 33314
Business Address 3321 COLLEGE AVENUE SUITE 246 DAVIE FL 33314 888-963-7881
Organicell Regenerative Medicine, Inc. (Filer) CIK: 0001557376 (see all company filings)

IRS No.: 474180540 | State of Incorp.: NV | Fiscal Year End: 1031
Type: DEF 14C | Act: 34 | File No.: 000-55008 | Film No.: 231499354
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)